The Outcomes of Keystone Perforator Island Flap Versus Lay Open in Re-recurrent Pilonidal Sinus Disease
1 other identifier
interventional
24
1 country
1
Brief Summary
Pilonidal disease is a common and annoying problem with a fair recurrence rate. Every time of recurrence more skin is needed to cover the defect and if left open healing is supposed to be prolonged.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable
Started Feb 2024
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
February 1, 2024
CompletedFirst Submitted
Initial submission to the registry
December 9, 2024
CompletedFirst Posted
Study publicly available on registry
December 19, 2024
CompletedPrimary Completion
Last participant's last visit for primary outcome
February 1, 2025
CompletedStudy Completion
Last participant's last visit for all outcomes
February 1, 2025
CompletedAugust 17, 2025
December 1, 2024
1 year
December 9, 2024
August 12, 2025
Conditions
Outcome Measures
Primary Outcomes (4)
operative time
operative time is measured in minutes from incision to wound dressing
bleeding amount
intra and post operative bleeding amount is measured in cc by volumetric method
amount of blood lost is measured from incision for 2 days post operative
healing time
healing time is measured for 3 months post-operatively
wound infection
wound infection evaluated by presence of pus from the first day post-operativel
wound infection is evaluated for 3 months post-operatively
Study Arms (2)
re- recurrent pilonidal sinus
ACTIVE COMPARATORre-recurrent pilonidal sinus
ACTIVE COMPARATORInterventions
facio-cutaneous flap used to cover the defect after removal of the disease
after removal of the disease, the wound is left open to heal by granulation tissue
Eligibility Criteria
You may qualify if:
- re-recurrent pilonidal disease
You may not qualify if:
- patients with proved anal or perineal malignancy or autoimmune disease
- patient with pilonidal disease for the first time or for the first time of recurrence
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Faculty of Medicine
Zagazig, Sharqia Province, 44519, Egypt
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER GOV
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- lecturer of general surgery, faculty of medicine, Zagazig University
Study Record Dates
First Submitted
December 9, 2024
First Posted
December 19, 2024
Study Start
February 1, 2024
Primary Completion
February 1, 2025
Study Completion
February 1, 2025
Last Updated
August 17, 2025
Record last verified: 2024-12